GPVI
Showing 1 - 13 of 13
Idiopathic Thrombocytopenic Purpura Trial in Cairo (Eltrombopag, conventional)
Completed
- Idiopathic Thrombocytopenic Purpura
-
Cairo, EgyptAinshams University , Faculty of medicine , Pediatric Hematology
Oct 26, 2021
Type 2 Diabetes, Postprandial Hyperglycemia Trial in Stockholm (Insulin aspart (Novorapid®))
Completed
- Type 2 Diabetes Mellitus
- Postprandial Hyperglycemia
- Insulin aspart (Novorapid®)
-
Stockholm, SwedenDepartment of Medicine, Clinical pharmacology Unit, Karolinska U
May 24, 2022
Platelet Inflammatory Response in NAFL and NASH
Recruiting
- NASH - Nonalcoholic Steatohepatitis
- NAFLD
- High fat meal in a subset of patients with NAFL or NASH
-
Rome, Italy
- +1 more
Dec 27, 2021
Acute Ischemic Stroke Trial in Bordeau (Intravenous glenzocimab (ACT017) 1000 mg, Intravenous Placebo)
Recruiting
- Acute Ischemic Stroke
- Intravenous glenzocimab (ACT017) 1000 mg
- Intravenous Placebo
-
Houston, Texas
- +1 more
Sep 28, 2022
Acute Ischemic Stroke Trial in Bordeau (Intravenous ACT017 1000 mg, Intravenous Placebo)
Completed
- Acute Ischemic Stroke
- Intravenous ACT017 1000 mg
- Intravenous Placebo
-
Bordeau, FranceCentre Hospitalier Universitaire de Bordeaux,
Oct 5, 2021
SARS-CoV Infection, Acute Respiratory Distress Syndrome, COVID-19 Trial in Strasbourg (glenzocimab, Placebo)
Completed
- SARS-CoV Infection
- +3 more
- glenzocimab
- Placebo
-
Strasbourg, FranceHôpital de Hautepierre
Sep 10, 2021
Primary Hemostasis Pathology in Patients on ECMO During Lung
Recruiting
- ECMO Primary Hemostasis Pathology
-
Prague, Česká Republika, CzechiaUH Motol
Oct 3, 2021
Carotid Stenosis, Atherosclerosis, Stroke Trial in Germany, United Kingdom (Revacept, Placebo)
Stable Coronary Artery Disease Trial in Germany (Revacept 80 mg, Revacept 160 mg, Placebo)
Completed
- Stable Coronary Artery Disease
- Revacept 80 mg
- +2 more
-
Munich, Bavaria, Germany
- +7 more
Apr 17, 2020
Thrombin Generation and Platelet Activation in CRS/HIPEC
Completed
- Mesothelioma; Peritoneum
- +2 more
- CRS/HIPEC
- (no location specified)
Jan 24, 2017
HIV, Cardiovascular Disease Trial in Melbourne (Abacavir)
Completed
- HIV
- Cardiovascular Disease
-
Melbourne, Victoria, AustraliaAlfred Health
May 21, 2015
Risk Factor in Thrombotic and/or Bleeding Complications
Completed
- Genetic Polymorphism
-
Nashville, TennesseeVanderbilt University Medical Center
Dec 16, 2013
Thrombosis, Acute Coronary Syndrome, Myocardial Infarction Trial in Goerlitz (revacept (PR-15))
Completed
- Thrombosis
- +3 more
- revacept (PR-15)
-
Goerlitz, Saxony, GermanyABX-CRO/Medifacts GmbH
Oct 18, 2012